Marco Cippitelli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Role of NF-κB Signaling in the Interplay between Multiple Myeloma and Mesenchymal Stromal Cells	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
NKG2D engagement on human NK cells leads to DNAM‐1 hypo‐responsiveness through different converging mechanisms	EUROPEAN JOURNAL OF IMMUNOLOGY	2023
Doxorubicin–Mediated miR–433 Expression on Exosomes Promotes Bystander Senescence in Multiple Myeloma Cells in a DDR–Independent Manner	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Impact on NK cell functions of acute versus chronic exposure to extracellular vesicle-associated MICA. Dual role in cancer immunosurveillance	JOURNAL OF EXTRACELLULAR VESICLES	2022
GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells	FRONTIERS IN IMMUNOLOGY	2022
Rescue SLAMF7 activity in exhausted natural killer cells: Novel challenges in the immunotherapy of multiple myeloma	CLINICAL AND TRANSLATIONAL DISCOVERY	2022
Role of aiolos and ikaros in the antitumor and immunomodulatory activity of imids in multiple myeloma: Better to lose than to find them	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2021
Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition	CELL DEATH & DISEASE	2021
Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation	EUROPEAN JOURNAL OF IMMUNOLOGY	2021
Hitting More Birds with a Stone: Impact of TGF-β on ILC Activity in Cancer	JOURNAL OF CLINICAL MEDICINE	2020
CD155: a multi-functional molecule in tumor progression	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2020
Bone marrow stromal cell-derived IL-8 upregulates PVR expression on multiple myeloma cells via NF-kB transcription factor	CANCERS	2020
Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer	FRONTIERS IN IMMUNOLOGY	2020
The Ubiquitin-proteasome pathway regulates Nectin2/CD112 expression and impairs NK cell recognition and killing.	EUROPEAN JOURNAL OF IMMUNOLOGY	2019
The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in multiple myeloma. modulation by bromodomain and Extra-Terminal (BET) protein inhibitors	CELL DEATH & DISEASE	2019
Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms	THE FASEB JOURNAL	2019
The POU-Domain Transcription Factor Oct-6/POU3F1 as a Regulator of Cellular Response to Genotoxic Stress	CANCERS	2019
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene	FRONTIERS IN IMMUNOLOGY	2019
NKG2D and its ligands: one for all, all for one	FRONTIERS IN IMMUNOLOGY	2018
Drug-induced senescent Multiple Myeloma cells elicit NK cell proliferation by direct or exosome-mediated IL-15 trans-presentation	CANCER IMMUNOLOGY RESEARCH	2018

ERC

LS6_1
LS6_3

KET

Life-science technologies & biotechnologies

Keywords

cancer immunotherapy

multiple myeloma

natural killer

Progetti di Ricerca

Harnessing NK cells by genetic and epigenetic rerouting to overcome Multiple Myeloma immune evasion.